NEI/FDA CDER Glaucoma Clinical Drug Trial Design and Endpoints Symposium

News Brief

Natcher Auditorium
National Institutes of Health
Bethesda, Maryland
March 13-14, 2008

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) are sponsoring a symposium to consider new disease-relevant outcome measures appropriate for evaluating glaucoma therapies.

For additional information and to register for the symposium, please visit the Association for Research
in Vision and Ophthalmology (ARVO) website at